Description
Cagrilintide is a long-acting amylin analog designed to mimic the effects of the naturally occurring hormone amylin. As a novel research compound, it has gained significant attention for its potential role in appetite regulation and metabolic function studies.
Research on Cagrilintide focuses on its ability to enhance satiety signaling, slow gastric emptying, and modulate glucagon secretion. When studied alongside GLP-1 receptor agonists, this compound has shown promising synergistic effects in metabolic research.
Research Applications
- Amylin receptor agonism and signaling
- Appetite and satiety regulation
- Gastric emptying modulation
- Glucagon secretion studies
- Weight management research
- GLP-1 combination studies
- Metabolic syndrome research
- Glucose homeostasis studies
Concentration: 5mg concentration provides researchers with an effective dose for investigating Cagrilintide’s metabolic and appetite-regulating effects.
FOR RESEARCH PURPOSES ONLY: This product is intended strictly for laboratory research and in vitro studies. Not approved for human consumption. This is not a drug, supplement, or food product. All research should comply with applicable regulations and be conducted by qualified individuals.
